Navigation Links
Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
Date:4/23/2008

Company reports more than 60 orders for faster form of image-guided

intensity-modulated radiation therapy

PALO ALTO, Calif., April 23 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced it has received more than 60 orders for its new RapidArc radiotherapy product for faster image-guided intensity-modulated radiotherapy (IMRT). RapidArc orders have been concentrated in North America but have also come in from Europe and Asia since the product was introduced to the market in January, according to the company.

"We are delighted with the early interest in RapidArc, which promises to be a formidable weapon in the battle against cancer," says Tim Guertin, president and CEO of Varian Medical Systems. "This represents the strongest demand for any new product in our history and reflects the need for faster, more user-friendly systems that enable clinics to offer more patients greater access to advanced image-guided IMRT treatments with precision and quality. With RapidArc, we are adding to the already-unsurpassed versatility and value of our Clinac(R) and Trilogy(R) accelerators, making it possible for clinics to use a broader range of imaging, motion management, and dose delivery techniques to deliver an optimal cancer treatment for each and every patient." The company expects to begin shipment of the RapidArc product before the end of this month.

RapidArc delivers a complete volumetric IMRT treatment in a single arc of the treatment machine around the patient and makes it possible to deliver advanced image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than is possible with conventional IMRT, including helical tomotherapy. Treatment planning analyse
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Gene Variant Boosts Risk for Stress-Related Ischemia
2. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
3. Gene Variant Protects Black Heart Failure Patients
4. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
5. Varian, Inc. Acquires Oxford Diffraction, Ltd.
6. Gene Variants Linked to Lung Cancer Identified
7. New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity
8. New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
9. FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis
10. Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship
11. Gene Variants Can Predict Threat of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 Due ... started to hire more caregivers, staffing personnel, and ... and care managers within the Greater Los Angeles ... training institution, 1Heart Caregiver University has firmed up ... its mission to provide quality in-home care through ...
(Date:3/31/2015)... Over the last several years, many improvements ... yielded better results and more efficient procedures. Similarly, the ... a good hair transplant surgeon, has resulted in astonishingly ... restoration have improved the efficiency of hair restoration procedures, ... precision and flexibility to the field of hair restoration. ...
(Date:3/31/2015)... 2015 In honor of National ... advice for buying from a NMEDA QAP certified ... is a nonprofit organization that provides consumer guidance ... and installation of mobility equipment. The organization’s Quality ... that consistently adhere to the highest quality safety ...
(Date:3/31/2015)... FL (PRWEB) March 31, 2015 Medical ... America, has met all criteria for Laboratory Accreditation by ... given only to laboratories that apply rigid standards of ... performance of proficiency testing, and pass a rigorous on-site ... COLA accreditation as a result of a long-term commitment ...
(Date:3/31/2015)... The Walk a Mile Project, as part of ... kicked off their 3rd research sequence. The new sequence ... Equivalence was and is a massive component of GMO ... Change The World Films. “We started our research by ... entered our food supply, just to get a bird's eye ...
Breaking Medicine News(10 mins):Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2
... Lynne Eldridge, M.D., author,of Avoiding Cancer One Day At ... common forms of cancer during a series of FREE seminars ... in downtown San Jose on,Sunday October 28th between 10am and ... the tech museum you can also visit the,amazing Body Worlds ...
... the University at Buffalo,s Research Institute on Addictions (RIA) ... technique often used in behavioral medicine for stress reduction ... of alcohol use disorders. , ... reduction or MBSR in alcoholism treatment, we hope to ...
... cut with more testing and early detection, , , FRIDAY, ... women think that if there,s no family history of ... new survey found. , In fact, most people who ... to the American College of Obstetricians and Gynecologists (ACOG), ...
... Oct. 26 Peak International Limited,(Nasdaq: PEAK ) ... fiscal year 2008 ended September 30, 2007 will be ... A conference call to,discuss the results of the quarter ... 2007 at 10:00 AM ET. To access the ...
... third quarter financial results -, LAVAL, QC, Oct. ... announced that it will host a conference call on,Friday, ... its third quarter,2007 financial results. Labopharm will report its ... 7:00 a.m. the same day. To access the ...
... by Truth Wins Out:, What: The National Association ... annual meeting at the Dallas/Ft. Worth,Airport Marriott on October ... heterosexuals with a homosexual problem." A coalition of local ... 11AM, followed,by a demonstration against this controversial fringe group ...
Cached Medicine News:Health News:Author Reveals How to Cancer Proof Your Life on October 28th 2Health News:Dealing with stress as a treatment for alcohol abuse 2Health News:Survey Finds Many Women Misinformed About Cancer 2Health News:Survey Finds Many Women Misinformed About Cancer 3Health News:Peak International Sets Time for Discussion of Second Quarter Fiscal 2008 Financial Results 2Health News:Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET) 2Health News:Major Protest On Saturday Against Fringe Therapists Who Claim to 'Cure' Gays 2
(Date:3/31/2015)... , March 31, 2015 Accelerated ... the American Association of Orthodontics 2015 Annual Session, ... orthodontists present scientific lectures on AcceleDent ® . ... leader in accelerated orthodontics, AcceleDent is a FDA-cleared, ... treatment by as much as 50 percent with ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
(Date:3/31/2015)... Ryan & Maniskas, LLP is ... Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: ... other violations of law related to the Company,s efforts ... a transaction valued at approximately $1.1 billion. ... to learn more about this class action or if ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2
... 25, 2011 Renowned biochemist Michael A. Marletta, ... as the next president of The Scripps Research Institute, effective ... MD, who has led the institution for 25 years. ... Marletta, past Chair of the Department of ...
... 2011 ERT (Nasdaq: ERES ), announced ... CEO, and Keith Schneck, the Company,s Chief Financial Officer, ... Health Care Conference at 10:00 AM ET on March 2, ... may access the presentation by visiting the Company,s corporate ...
Cached Medicine Technology:The Scripps Research Institute Names Michael A. Marletta as President 2The Scripps Research Institute Names Michael A. Marletta as President 3The Scripps Research Institute Names Michael A. Marletta as President 4ERT to Present at the Citi 2011 Global Health Care Conference on March 2, 2011 2
...
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Medicine Products: